World Haemophilia Day 2017

Today is WHD 2017, a tribute to all people living with congenital haemophilia and other bleeding disorders - and an important opportunity to increase awareness about these diseases. Although solid progress in treatment has been made over the past decades, daily life with a bleeding disorder continues to present significant challenges, limitations, concerns and risks of long-term deteriorating health. 

Novo Nordisk is committed to improving access to diagnosis and treatment of haemophilia and dedicated to developing innovative new medicines - to improve options for care and the lives of all patients with haemophilia.

To learn more, please follow the link: www.novonordisk.com/about-novo-nordisk/changing-haemophilia/world-haemophilia-day.html